Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 149 Docetaxel 139 Paclitaxel 127 Trastuzumab 120 Tamoxifen 110 Capecitabine 104 Letrozole 92 Epirubicin 79 Doxorubicin 70 Anastrozole 70 exemestane 67 Fulvestrant 65 Fluorouracil 61 Radiotherapy 60 pertuzumab 40 Gemcitabine 39 Carboplatin 38 Vinorelbine 34 Goserelin 34 Bevacizumab 29 Zoledronic Acid 28 Methotrexate 28 Chemotherapy, Adjuvant 28 eribulin 27 Lapatinib 25 ribociclib 24 palbociclib 24 Drug Therapy 22 130-nm albumin-bound paclitaxel 20 pegfilgrastim 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Neoplasms × BAY 86-7548 × Clear all

NCT03731026 2018-11-06

The LightPath® and 68Ga-RM2 in Breast Cancer Study

Lightpoint Medical Limited

Phase 3 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡